Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Natural anti-HIV agent disclosed by Hoechst

Dec. 16, 1997

Peptimmune acquires option for HIV vaccine-related technology from MGH

Dec. 15, 1997

Ligand reports positive results from U.S. pivotal phase III trial of Panretin Gel

Dec. 12, 1997

Alferon N Injection completes phase III in HIV

Dec. 12, 1997

Immune Response recommended to continue Remune phase III trial

Dec. 12, 1997

Cel-Sci AIDS vaccine effective in mouse model of HIV and immunogenic in humans

Dec. 11, 1997

Antisense AIDS therapy from Novopharm Biotech enters clinical trials

Dec. 10, 1997

HBY-097 + lamivudine highly effective against HIV-1 replication in vitro

Dec. 10, 1997

Adefovir dipivoxil now available in expanded access program

Dec. 9, 1997

PMPA prodrug with favorable biological/pharmaceutical properties

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...